The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hill Nancy Louise since 2019.
This trader's CIK number is 1780790.
At the time of last reporting, Hill Nancy Louise was the EVP, Operations & Program Mana of Adaptive Biotechnologies Corp. (stock ticker symbol ADPT).
Also see all insider trading activities at Adaptive Biotechnologies Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ADPT | 0 | $0 | 25,000 | $1,725,000 | 25,000 | $61,375 |
| 2020 | ADPT | 0 | $0 | 198,000 | $9,654,761 | 198,000 | $166,320 |
| 2019 | ADPT | 11,200 | $224,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-19 | ADPT | Sale | 25,000 | 69.00 | 1,725,000 |
| 2021-01-19 | ADPT | Option Ex | 25,000 | 2.46 | 61,375 |
| 2020-12-22 | ADPT | Option Ex | 57,000 | .84 | 47,880 |
| 2020-12-22 | ADPT | Sale | 57,000 | 63.79 | 3,636,030 |
| 2020-12-14 | ADPT | Option Ex | 40,000 | .84 | 33,600 |
| 2020-12-14 | ADPT | Sale | 40,000 | 59.00 | 2,360,000 |
| 2020-08-03 | ADPT | Sale | 1,600 | 37.37 | 59,791 |
| 2020-08-03 | ADPT | Option Ex | 1,600 | .84 | 1,344 |
| 2020-07-09 | ADPT | Option Ex | 17,400 | .84 | 14,616 |
| 2020-07-09 | ADPT | Sale | 17,400 | 49.00 | 852,600 |
| 2020-07-01 | ADPT | Option Ex | 3,000 | .84 | 2,520 |
| 2020-07-01 | ADPT | Sale | 3,000 | 47.52 | 142,560 |
| 2020-06-22 | ADPT | Sale | 19,000 | 45.02 | 855,380 |
| 2020-06-22 | ADPT | Option Ex | 19,000 | .84 | 15,960 |
| 2020-01-06 | ADPT | Option Ex | 60,000 | .84 | 50,400 |
| 2020-01-06 | ADPT | Sale | 60,000 | 29.14 | 1,748,400 |
| 2019-07-01 | ADPT | Buy | 11,200 | 20.00 | 224,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hill Nancy Louise (EVP, Operations & Program Mana of Adaptive Biotechnologies Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.